Solteq (SOLTEQ) Q3 2025 earnings summary

Executive summary

• Revenue and profitability declined year-over-year, with a focus on cost control and operational efficiency to address market headwinds.

• The company is prioritizing strengthening competitiveness and customer value, especially in challenging market conditions.

• Management remains confident in the long-term strategy despite short-term setbacks.

Financial highlights

• Q3 revenue was EUR 10.4 million, down 9.1% year-over-year; comparable revenue fell 5.2%.

• Q3 comparable EBITDA was EUR 0.4 million, a 59.7% decrease year-over-year.

• Q3 operating result was EUR 0.1 million, down 73.1% year-over-year.

• Earnings per share for Q3 was EUR -0.03, unchanged from the prior year.

• Net cash flow from operating activities for the first nine months was EUR -1.3 million.

Outlook and guidance

• Comparable revenue is expected to decrease slightly for 2025, but the comparable operating result is projected to improve significantly.

• Excluding the divested healthcare software business, comparable revenue for 2024 was EUR 48.8 million and comparable operating result was EUR 0.7 million.